Stay
Up-To-Date
Articles, publications, podcasts, and more to keep you current on our Vanquish Water Vapor Ablation System.
Francis Medical Announces First Commercial Vanquish® Procedure on the East Coast for Prostate Tissue Ablation
Minneapolis, MN [March. 25, 2026] – Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish® Water Vapor Ablation System, a minimally invasive technology designed to ablate targeted prostate tissue while potentially helping to preserve urinary and sexual function....
Learn More >
Francis Medical Announces First Commercial Vanquish® Procedures in Arizona for Prostate Tissue Ablation
MINNEAPOLIS (March 5, 2026) – Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water Vapor Ablation System for prostate tissue ablation....
Learn More >
Francis Medical Announces First Commercial Procedure with the Vanquish® Water Vapor System for Prostate Tissue Ablation
MINNEAPOLIS (Feb 3, 2026) – Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System...
Learn More >
Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation
MINNEAPOLIS (Dec. 2, 2025) – Francis Medical, Inc.,a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System ...
Learn More >
Press Release: Francis Medical Announces Completion of Enrollment in the VAPOR 2 Pivotal Study for Vanquish Prostate Cancer Treatment
February 25, 2025: Francis Medical completes enrollment in the company's VAPOR 2 Pivotal Study for Vanquish Prostate Cancer Treatment...
Learn More >
Press Release: Francis Medical Announces Close of Record $80 Million Series C Equity Financing
January 8, 2025: Francis Medical raises record $80M in Series C to fund its VAPOR 2 study and U.S. launch of Vanquish, its proprietary prostate cancer treatment...
Learn More >
Follow Us
We’re Here
To Help.
We’d love to connect. Follow us on social media or complete the form to ask a question or to be added to our company communications.


Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.